ask="6.80"
ask_size="200"
average_daily_volume="212715"
bid="N/A"
bid_size="N/A"
book_value="3.20"
change="-0.20"
change_from_200_day_moving_average="-5.41"
change_from_50_day_moving_average="-1.00"
change_from_52_week_high="-12.90"
change_From_52_week_low="0.05"
change_in_percent="-4.00%"
close="4.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.50"
ebitda="-18.94M"
eps_estimate_current_year="-2.77"
eps_estimate_next_quarter="-0.92"
eps_estimate_next_year="-2.52"
ex_dividend_date="N/A"
float_shares="5820000"
high="5.00"
high_52_weeks="17.70"
last_trade_date="1/26/2017"
last_trade_price="4.80"
last_trade_size="100"
last_trade_time="3:59pm"
low="4.75"
low_52_weeks="4.75"
market_capitalization="37.52M"
moving_average_200_day="10.21"
moving_average_50_day="5.80"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.70"
open="5.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-52.99%"
percent_change_from_50_day_moving_average="-17.18%"
percent_change_from_52_week_high="-72.88%"
percent_change_from_52_week_low="+1.05%"
previous_close="5.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.56"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="1.46"
stock_exchange="NCM"
symbol="TRIL"
volume="86734"
weeks_range_52="4.75 - 17.70"
